Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRONOUNCE: Pemetrexed + Carboplatin vs Paclitaxel + Carboplatin + Bevacizumab in Nonsquamous NSCLC
NCT00948675Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2009
- Primary completion
- Jan 2013
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Eli Lilly and Company. Started Sep 2009; status: completed.
02
Drugs
pemetrexed
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT00948675.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00948675.